{"id":"W2747775477","doi":"10.1016/j.ahj.2017.08.011","title":"International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries","year":2017,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Janssen Pharmaceuticals; AstraZeneca; Allergan; Sirtex Medical; Duke Clinical Research Institute; Eisai; ARCA Biopharma; Genentech; Zafgen; Janssen Scientific Affairs; Bayer HealthCare; Sanofi; Kowa Company; Boston Scientific Corporation; Daiichi-Sankyo; Teva Pharmaceutical Industries; Stanford Bio-X; Daiichi Sankyo Europe; Gilead Sciences; GlaxoSmithKline; National Heart, Lung, and Blood Institute; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; American Heart Association","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Vitamin K antagonist; Internal medicine; Cardiology; Coronary artery disease; Orbit (dynamics); Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001792429,0.0001702663,0.0004156893,0.001855949,0.0001936538,0.0006677881,0.0003134742,0.0003044359,0.0007111253],"category_scores_gemma":[0.004063772,0.0001224566,0.0007651271,0.00413408,0.0001536273,0.0006790684,0.0004557593,0.0003713937,0.0001851527],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000449598,"about_ca_system_score_gemma":0.0006542223,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0123027,"about_ca_topic_score_gemma":0.01473002,"domain_scores_codex":[0.99873,0.000199716,0.000314956,0.0002974,0.0003080643,0.0001499028],"domain_scores_gemma":[0.9950959,0.0006188217,0.003038353,0.0002183068,0.0006618215,0.0003667362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0000786465,0.00001219074,0.9971059,0.00002935623,0.00007623531,0.00001158806,0.00003803655,0.0000486966,0.00003467498,0.00003202199,0.0005446809,0.001987989],"study_design_scores_gemma":[0.0000117324,0.00002395082,0.9991358,0.00001830505,0.00004494944,0.00007766455,0.00009128058,0.0001031627,0.00001822618,0.0000152131,0.0004566121,0.000003172065],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9759684,0.002777896,0.0002547501,0.0003369331,0.00002157027,0.00002997026,0.01826169,0.00002402411,0.002324783],"genre_scores_gemma":[0.9800783,0.001467948,0.0002530169,0.0001828075,0.0000328844,0.00005190527,0.01766754,0.0000108115,0.0002547602],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0123027,"threshold_uncertainty_score":0.02446216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09411720450736344,"score_gpt":0.3956552734359698,"score_spread":0.3015380689286064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}